Pfizer Clarifies Covid-19 Vaccine Storage Concerns for India Market

0
American pharmaceutical giant Pfizer, which sought approval from India's drug regulator Drugs Controller General of India ((DGCI) for emergency use authorisation of its coronavirus vaccine, clarified storage concerns about its vaccine. Pfizer requires a temperature of minus 70 degrees Celsius and experts have raised questions that India's existing cold storage facilities do not match these conditions. Pfizer told NDTV in...

17 Volunteers Given Sputnik V Vaccine During Clinical Trial In Pune

0
A total of 17 volunteers have been administered Russia's Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said today. Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF). According to reports, India has purchased 100 million doses of the candidate...

Pfizer Seeks India Approval For Covid Vaccine, First To Do So: Sources

0
American pharma giant Pfizer has sought approval from the country's drug regulator - the DCGI (Drugs Controller General of India) - for emergency use authorisation of its coronavirus vaccine, say sources. The vaccine is ready to be rolled out in the United Kingdom and Bahrain. This is the first such request received by the DCGI amid the race to...

Delhi Seeks Health Workers’ Data For Covid Vaccine By Dec 5 Midnight

0
The Delhi government has directed all public and private medical facilities to finish enrolling their healthcare workers by December 5 midnight for a COVID-19 vaccine, which should be available in a few weeks.  According to sources, many registered and non-registered facilities have already submitted this data as the process had started in October.   The government-run facilities that have not completed the task...

UK To Vaccinate People Against Covid From Next Week, Clears Pfizer Shot

0
Britain approved Pfizer's COVID-19 vaccine on Wednesday, jumping ahead of the United States and Europe to become the West's first country to formally endorse a jab it said should reach the most vulnerable people early next week. Prime Minister Boris Johnson touted the medicine authority's approval as a global win and a ray of hope amid the gloom of the...

Centre Rejects Volunteer’s Claim, Clears Oxford Vaccine Trials In India

0
The government today said it had found no reason to stop the Oxford vaccine trials in India after reviewing a Chennai volunteer's allegation of serious adverse effects, including memory loss and change in behavior. The Adar Poonawalla-led Serum Institute of India (SII) also said the vaccine was "safe and immunogenic" and the Data and Safety Monitoring Board and the Ethics...

Serum Institute Files 100 Crores Case After Man Says Vaccine Left Him Ill

0
The Serum Institute of India has responded to "malicious and misconceived" allegations by preparing a ₹ 100 crore defamation suit against a Covishield coronavirus vaccine trial participant who claimed to suffer a "virtual neurological breakdown" after being administered a dose. the Serum Institute said that while it sympathised with the volunteer's medical condition there was "absolutely no correlation with...

Russia’s Sputnik V Covid-19 Vaccine To Be Produced In India

0
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), and Hetero, one of India's leading generic pharma companies (through its biologics arm “Hetero Biopharma”), have agreed to produce in India over 100 million doses per year of the world's first registered vaccine against the novel coronavirus infection — Sputnik V. The parties plan to start the production of Sputnik...

In a First For Southeast Asia, Malaysia Signs Deal With Pfizer for Vaccine

0
Malaysia has agreed to buy 12.8 million doses of Pfizer's COVID-19 vaccine, becoming the first country in Southeast Asia to announce a deal with the US drugmaker after some expressed reservations over the need for ultra-cold storage. While final trial data showed that Pfizer's vaccine is 95 per cent effective, many Asian countries are not betting on it partly due...

Oxford Vaccine Faces More Questions After AstraZeneca Admits Error

0
AstraZeneca Plc and the University of Oxford, among the front-runners in the quest to deliver a Covid-19 vaccine, face mounting questions about their trial results after acknowledging a manufacturing error. While an announcement Monday by Astra and Oxford showed their shot was 70% effective on average in a late-stage study, the scant details released by the UK partners have sparked...